Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Boehringer Ingelheim
Fish and Richardson
Mallinckrodt
Queensland Health
Cipla
Daiichi Sankyo
Accenture
Dow

Generated: April 24, 2018

DrugPatentWatch Database Preview

DEL-VI-A Drug Profile

« Back to Dashboard

Which patents cover Del-vi-a, and what generic alternatives are available?

Del-vi-a is a drug marketed by Del Ray Labs and is included in one NDA.

The generic ingredient in DEL-VI-A is vitamin a palmitate. There are forty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vitamin a palmitate profile page.
Drug patent expirations by year for DEL-VI-A
Synonyms for DEL-VI-A
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-en-1-yl)-2,4,6,8-nonateetraen-1-yl-palmitate
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl hexadecanoate
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl palmitate
(2E,4E,6E,8E)-Hexadecanoic acid 3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2, 4,6,8,tetraenyl ester
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenyl] hexadecanoate
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
108066-99-5
110067-62-4
1D1K0N0VVC
2840-EP2305825A1
3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl hexadecanoate
3,7-Dimethyl-9-(2,6,6,-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol palmitate
37340-08-2
674786-07-3
7488-89-3
79-81-2
A839762
AB00052360_04
AC-20001
AC1NQX64
AC1Q2W2H
AC1Q65TE
AK307659
AKOS015918435
ALL TRANS-RETINOL PALMITATE
all-trans-Retinol palmitate
all-trans-retinyl hexadecanoate
all-trans-Retinyl palmitate
all-trans-Vitamin A palmitate
AN-24005
Aquapalm
Aquasol A (TN)
Arovit
Arovit (Roche)
Axerophthol palmitate
BC215972
bmse000501
BRN 1917366
C02588
C36H60O2
CAS-79-81-2
CCG-39342
CCRIS 3280
CHEBI:17616
CHEMBL1675
D00164
Dispatabs Tabs
DSSTox_CID_1241
DSSTox_GSID_21241
DSSTox_RID_76033
DTXSID1021241
EINECS 201-228-5
Ester found in fish liver oils
hexadecanoic acid [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenyl] ester
HMS1922E10
HMS2093G13
HMS2268C06
HMS500M11
I14-7612
IDI1_000249
LMPR01090013
LP000472
LS-2307
Lutavit A 500 Plus
MFCD00019414
MLS001332437
MLS001332438
MolPort-003-666-488
NCGC00095056-01
NCGC00095056-02
NCGC00095056-03
NCGC00256427-01
NSC-758478
NSC758478
O~15~-hexadecanoylretinol
O~15~-palmitoylretinol
o15-palmitoylretinol
Optovit A
Optovit-A
Palmitic acid retinol
Palmitic acid, ester with retinol
Pharmakon1600-01503604
Retinol palmitate
Retinol palmitate (6CI,7CI)
Retinol palmitate (JP17)
retinol-palmitate
Retinol, all-trans-, palmitate
Retinol, hexadecanoate
retinol, O~15~-(1-oxohexadecyl)-
Retinol, palmitate, all-trans-
Retinol, palmitate, all-trans- (8CI)
Retinyl hexadecanoate
Retinyl hexadecanoic acid
retinyl palmitate
Retinyl Palmitate (Vitamin A Palmitate), pharmaceutical secondary standard; traceable to USP
Retinyl palmitate solution, 100 mug/mL (Ethanol with 0.1% (w/v) BHT), ampule of 1 mL, certified reference material
Retinyl palmitate, potency: >=1,700,000 USP units per g
Retinyl palmitate, Type IV, ~1,800,000 USP units/g, oil
Retinyl palmitate, United States Pharmacopeia (USP) Reference Standard
Retinyl palmitic acid
S302
s4126
SBI-0051830.P002
SC-15989
SCHEMBL41649
SMR000112463
SPECTRUM1503604
Spectrum5_001201
SR-05000001910
SR-05000001910-1
ST51055690
Tox21_113452
Tox21_303008
trans-Retinol palmitate
trans-Retinyl palmitate
UNII-1D1K0N0VVC
UNII-81G40H8B0T component VYGQUTWHTHXGQB-FFHKNEKCSA-N
VITAMIN A PALMITATE
Vitamin A palmitate, 1.7 M.I.U./g
Vitamin A Solubilized
Vitamin A, palmitate
Vitamin- A palmitate
Vitazyme A
VYGQUTWHTHXGQB-FFHKNEKCSA-N
ZINC8214494

US Patents and Regulatory Information for DEL-VI-A

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Del Ray Labs DEL-VI-A vitamin a palmitate CAPSULE;ORAL 080830-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Medtronic
Dow
Farmers Insurance
QuintilesIMS
Federal Trade Commission
Fish and Richardson
Deloitte
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.